Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.44 USD | -0.67% |
|
-7.69% | +14.46% |
04-30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
04-29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.46% | 475M | |
+2.52% | 92.1B | |
-2.63% | 37.92B | |
-13.57% | 32.97B | |
+75.60% | 27.92B | |
-12.73% | 16.14B | |
-2.15% | 14.1B | |
-11.93% | 11.66B | |
+177.66% | 10.29B | |
-50.94% | 9.99B |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- Transcript : Peregrine Pharmaceuticals, Inc., Q3 2014 Earnings Call, Mar 07, 2014